pyrimidine has been researched along with Lung Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Wang, H; Wang, X; Xu, L; Zhang, J | 1 |
| Bhaskaran, S; Bhat, SA; D, P; M, SAP; Nallajennugari, V; Pajaniradje, S; Rajagopalan, R; Subramanian, S | 1 |
2 other study(ies) available for pyrimidine and Lung Adenocarcinoma
| Article | Year |
|---|---|
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
Topics: Adenocarcinoma of Lung; Biomarkers, Tumor; Databases, Genetic; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lung; Lung Neoplasms; Prognosis; Pyrimidines; Signal Transduction | 2020 |
A novel anticancer chromeno-pyrimidine analogue inhibits epithelial-mesenchymal transition in lung adenocarcinoma cells.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Molecular Docking Simulation; Pharmaceutical Preparations; Pyrimidines | 2021 |